SWP
TEVA icon

Stratos Wealth Partners’s Teva Pharmaceuticals TEVA Stock Holding History

Stratos Wealth Partners’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$406K Buy
13,465
+132
+1% +$4.25K ﹤0.01% 1155
2025
Q4 		$416K Buy
13,333
+147
+1% +$3.62K ﹤0.01% 1122
2025
Q3 		$266K Buy
+13,186
New +$232K ﹤0.01% 1311
2020
Q3 		– Sell
-21,110
Closed -$260K – 1059
2020
Q2 		$260K Sell
21,110
-3,450
-14% -$39K 0.01% 810
2020
Q1 		$221K Buy
24,560
+14,000
+133% +$143K 0.01% 783
2019
Q4 		$103K Buy
+10,560
New +$94.3K ﹤0.01% 951
2018
Q4 		– Sell
-3,690
Closed -$79K – 2329
2018
Q3 		$79K Buy
+3,690
New +$85.7K ﹤0.01% 1251
2018
Q2 		– Sell
-4,039
Closed -$69K – 2408
2018
Q1 		$69K Sell
4,039
-1,111
-22% -$21.7K ﹤0.01% 1405
2017
Q4 		$98K Buy
+5,150
New +$77.5K ﹤0.01% 1199
2017
Q1 		– Sell
-9,969
Closed -$361K – 855
2016
Q4 		$361K Sell
9,969
-5,602
-36% -$224K 0.02% 469
2016
Q3 		$716K Buy
15,571
+2,303
+17% +$120K 0.05% 289
2016
Q2 		$666K Buy
13,268
+8,768
+195% +$467K 0.05% 283
2016
Q1 		$241K Buy
4,500
+592
+15% +$34.7K 0.02% 471
2015
Q4 		$257K Buy
+3,908
New +$242K 0.02% 462
2015
Q1 		– Sell
-3,551
Closed -$204K – 633
2014
Q4 		$204K Buy
+3,551
New +$198K 0.04% 447

Other funds holding TEVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Stratos Wealth Partners's TEVA Position: Q1 2026 in Review

Stratos Wealth Partners increased its Teva Pharmaceuticals (TEVA) stake by 0.99% in Q1 2026, buying an estimated $4.25K and bringing the position to 13,465 shares worth $406K. The position accounts for ﹤0.01% of the portfolio, ranked #1155.

Stratos Wealth Partners first reported a position in TEVA in Q4 2014 and has held it in 15 quarters since. The position peaked at $716K in Q3 2016. 650 funds tracked by Wall St. Rank hold TEVA as of Q1 2026.

  • Stratos Wealth Partners held 13,465 shares of Teva Pharmaceuticals worth $406K as of Q1 2026.
  • Stratos Wealth Partners bought 132 Teva Pharmaceuticals shares in Q1 2026, an estimated $4.25K.
  • Teva Pharmaceuticals made up ﹤0.01% of Stratos Wealth Partners's portfolio in Q1 2026, its #1155 holding.
  • Stratos Wealth Partners first reported a position in Teva Pharmaceuticals in Q4 2014 and has held it in 15 quarters since.
  • Stratos Wealth Partners's Teva Pharmaceuticals position peaked at $716K in Q3 2016.
  • 650 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2026.

Based on Stratos Wealth Partners's 13F filing for Q1 2026, filed 28 Apr 2026.